- Home
- NNNN vs CLNE Comparison
NNNN vs CLNE Comparison
Compare NNNN & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- CLNE
- Stock Information
- Founded
- NNNN 2021
- CLNE 2001
- Country
- NNNN Germany
- CLNE United States
- Employees
- NNNN N/A
- CLNE N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CLNE Natural Gas Distribution
- Sector
- NNNN Health Care
- CLNE Utilities
- Exchange
- NNNN Nasdaq
- CLNE Nasdaq
- Market Cap
- NNNN 369.6M
- CLNE 433.1M
- IPO Year
- NNNN 2025
- CLNE 2007
- Fundamental
- Price
- NNNN $49.26
- CLNE $2.19
- Analyst Decision
- NNNN
- CLNE Strong Buy
- Analyst Count
- NNNN 0
- CLNE 3
- Target Price
- NNNN N/A
- CLNE $4.33
- AVG Volume (30 Days)
- NNNN 220.1K
- CLNE 2.7M
- Earning Date
- NNNN 01-01-0001
- CLNE 08-06-2025
- Dividend Yield
- NNNN N/A
- CLNE N/A
- EPS Growth
- NNNN N/A
- CLNE N/A
- EPS
- NNNN 0.06
- CLNE N/A
- Revenue
- NNNN $8,185,146.00
- CLNE $415,920,000.00
- Revenue This Year
- NNNN N/A
- CLNE $2.47
- Revenue Next Year
- NNNN N/A
- CLNE $9.38
- P/E Ratio
- NNNN $908.77
- CLNE N/A
- Revenue Growth
- NNNN 21.95
- CLNE 4.85
- 52 Week Low
- NNNN $5.18
- CLNE $1.30
- 52 Week High
- NNNN $53.11
- CLNE $3.67
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- CLNE 62.96
- Support Level
- NNNN N/A
- CLNE $2.00
- Resistance Level
- NNNN N/A
- CLNE $2.26
- Average True Range (ATR)
- NNNN 0.00
- CLNE 0.11
- MACD
- NNNN 0.00
- CLNE 0.03
- Stochastic Oscillator
- NNNN 0.00
- CLNE 86.27
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About CLNE Clean Energy Fuels Corp.
Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.